MD Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. (MD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $855.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Weis Shirley A | Director | Sell | 36,028 | $23.75 | $855.7K | None left | |
| ORDAN MARK S | Chief Executive Officer | Sell | 23,000 | $22.41 | $515.4K | 302,805 −7.1% of holding | |
| Rucker Michael A. | Director | Sell | 10,478 | $23.00 | $241.0K | 59,101 −15.1% of holding | |
| Linynsky Laura A | Director | Sell | 10,000 | $21.65 | $216.5K | 32,232 −23.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.